Transparency in 340B: Why it Matters

Passed by Congress in 1992, the 340B drug pricing program has become an essential component of the healthcare safety-net in America. The program was designed to help covered entities “stretch scarce federal resources as far as possible, reaching more eligible patients and providing more comprehensive services.” H.R. Rep. No. 102-384(II), at 12 (1992)

Savings directly related to this program can be used to expand the areas of care that eligible entities offer. This is especially important for providers located in low income, underserved rural areas, or those which serve a high number of indigent patients. Click here.

340B revenues can be utilized to cover operational costs or otherwise advance the scope of care eligible entities can provide for vulnerable populations.

Smaller Entities May Lack the Resources to Implement a 340B Program
Many covered entities however, lack the resources to properly stock, track and dispense medications while remaining fully compliant with complex 340B program requirements. This is where the contract pharmacy affiliate program comes into play.

340B Solutions: Partner Pharmacies
By partnering with pharmacies, covered entities gain access to discounted medications at the 340B ceiling price. (Average manufacturer price, or AMP, minus the unit rebate amount, or URA.)

These medications can then be dispensed on behalf of the covered entity, without adding substantial associated costs such as having an in-house pharmacy and or on-site inventory.

We Help Providers Increase 340B Revenue Streams While Lowering Costs
Choosing a contracting pharmacy directly impacts not only how much you save, but how much you get back. Additionally, some pharmacies include hidden fees that eat up desperately needed revenues, lowering the effectiveness of the 340B program.